Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety. Journal of Psychopharmacology, 25, 1199-1206. Epub 2011 May 9.
Bailey, J.E., Papadopoulos., A, Diaper, A., Phillips, S., Schmidt, M.E., van der Ark, P., Dourish, C.T., Dawson, G.R. and Nutt, D.J. (2011).